home / stock / onvo / onvo quote
Last: | $0.96 |
---|---|
Change Percent: | -4.4% |
Open: | $0.95 |
Close: | $0.96 |
High: | $0.99 |
Low: | $0.89 |
Volume: | 283,862 |
Last Trade Date Time: | 05/08/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.96 | $0.95 | $0.96 | $0.99 | $0.89 | 283,862 | 05-08-2024 |
$0.91 | $0.95 | $0.91 | $0.96 | $0.8999 | 193,589 | 05-07-2024 |
$0.95 | $0.9817 | $0.95 | $1.01 | $0.95 | 214,964 | 05-06-2024 |
$1.03 | $0.95 | $1.03 | $1.17 | $0.95 | 1,110,523 | 05-03-2024 |
$0.9504 | $0.93 | $0.9504 | $0.9611 | $0.93 | 88,272 | 05-02-2024 |
$0.9311 | $0.98 | $0.9311 | $1.02 | $0.9305 | 381,336 | 05-01-2024 |
$1.07 | $1.05 | $1.07 | $1.09 | $1.0256 | 74,678 | 04-30-2024 |
$1.04 | $0.99 | $1.04 | $1.06 | $0.99 | 111,842 | 04-29-2024 |
$1 | $0.9881 | $1 | $1.0256 | $0.9801 | 139,374 | 04-26-2024 |
$0.9881 | $0.98 | $0.9881 | $1.02 | $0.98 | 72,927 | 04-25-2024 |
$1 | $0.99 | $1 | $1.03 | $0.99 | 116,976 | 04-24-2024 |
$1 | $1 | $1 | $1.06 | $1 | 124,528 | 04-23-2024 |
$1.03 | $1.07 | $1.03 | $1.12 | $1.012 | 297,906 | 04-22-2024 |
$1.1 | $1.15 | $1.1 | $1.19 | $1.1 | 275,808 | 04-19-2024 |
$1.15 | $1.1 | $1.15 | $1.29 | $1.09 | 579,006 | 04-18-2024 |
$1.12 | $1.11 | $1.12 | $1.21 | $1.05 | 550,867 | 04-17-2024 |
$1.15 | $1.28 | $1.15 | $1.3 | $1.1 | 1,941,464 | 04-16-2024 |
$1.35 | $1.66 | $1.35 | $1.74 | $1.2 | 53,785,457 | 04-15-2024 |
$1.0101 | $1.02 | $1.0101 | $1.04 | $1 | 53,109 | 04-12-2024 |
$1.0301 | $1.02 | $1.0301 | $1.0399 | $1.01 | 11,130 | 04-11-2024 |
News, Short Squeeze, Breakout and More Instantly...
Organovo Holdings Inc. Company Name:
ONVO Stock Symbol:
NASDAQ Market:
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology ...
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D...
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the P...